×

Sagent Pharmaceuticals and the Chicago Innovation Awards to Ring NASDAQ

Sagent's Heparin Product Family

SCHAUMBURG, Ill., March 31, 2014 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) will join the Chicago Innovation Awards, the Chicago region's foremost annual celebration of innovation, in New York City on Monday, March 31, to close the NASDAQ Stock Market, the premier exchange for technology companies. The event, arranged by the Chicago Innovation Awards, will emphasize the surge of innovation that is occurring in the Chicago region and shine a spotlight on the organizations that make up its vibrant economy.

Sagent's Heparin Product Family


"This annual event is an excellent example of how the Chicago Innovation Awards celebrate the spirit of innovation in organizations across all industries, sizes and sectors," said Tom Kuczmarski, Co-Founder of the Chicago Innovation Awards.

"We congratulate Sagent Pharmaceuticals for winning the Chicago Innovation Awards, and applaud their commitment to innovation," said Dan Miller, fellow Co-Founder.

Joining Sagent Pharmaceuticals will be fellow winners of the 2013 Chicago Innovation Awards including Anova Technologies, Autonomy Works, Belly, Braintree, Chicago Public Library, Everpurse, FarmedHere, FarmLogix, First Alert, iLight Technologies, Ingenuity, Life Spine, Moxie Jean, Nordic Auto Plow, Portapure, Protein Bar, Rabine Group, SceneTap, SimpleRelevance, SiNode Systems, SwipeSense and tastytrade.

"We are delighted to be recognized by the Chicago Innovation Awards and we'd also like to salute our fellow winners. When fewer than three percent of nominees from an extremely competitive field are chosen as award winners, you know you are in very good company," said Jeffrey M. Yordon, Chief Executive Officer and Chairman of the Board of Sagent. "For us, having an independent third party acknowledge the importance of our innovation to patients and caregivers throughout the United States is both humbling and gratifying. We continue to work tirelessly to advance patient safety and are also spreading the word to encourage others to strive to help reduce the risk of medication errors."

Sagent Pharmaceuticals is a leading provider of specialty pharmaceuticals that distinguishes itself from "typical pharma" in several ways. Sagent has a unique business model, a nimble global development and delivery network and a proprietary approach to packaging and labeling – PreventIV MeasuresSM Packaging and Labeling that creates a unique design for each of its drugs, as well as using distinctive colors within that design to highlight different strengths. Sagent's highly differentiated packaging and labeling helps to make accurate medication selection an easy and obvious choice for caregivers.

Sagent's award-winning innovation is its line of Heparin Sodium Injection, USP products with PreventIV Measures Packaging and Labeling. Heparin is an anticoagulant that is manufactured in numerous strengths that are used in a wide variety of procedures in hospital populations of all ages. Nearly all other manufacturers use a template label approach to their drugs, increasing the possibility that caregivers may confuse dosage strengths, which can have very serious consequences for patients. Sagent's heparin with PreventIV Measures Packaging and Labeling offers nine different product codes, each labeled with an easy-to-read drug name and dosage strength as well as a distinctive color. With these easy-to-distinguish heparin products, Sagent is helping to reduce the risk of medication errors among healthcare professionals throughout the chain of care.

Sagent's Heparin Product Family

http://www.globenewswire.com/newsroom/prs/?pkgid=24440

About Sagent Pharmaceuticals, Inc.

Sagent Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing, manufacturing, sourcing and marketing pharmaceutical products, with a specific emphasis on injectables. Sagent has created a unique global network of resources, comprising rapid development capabilities, sophisticated manufacturing and innovative drug delivery technologies, resulting in an extensive and rapidly expanding pharmaceutical product portfolio that fulfills the evolving needs of patients.

About The Chicago Innovation Awards

The Chicago Innovation Awards, established in 2002, have grown from a single awards ceremony to a year-long series of events and activities designed to celebrate innovation in the Chicago region, educate people and organizations about the principles of innovation, and connect the corners of the economy by building relationships that strengthen companies, grow the economy and create jobs. The organization's expansion has included formation of the Chicago Innovation Foundation, which promotes innovation education and provides scholarships to college students each year, as well as The Innovators Connection, which connects large companies with Chicago-based start-ups.

For more information, visit www.chicagoinnovationawards.com.

CONTACT: INVESTOR CONTACT: Jonathon Singer, Sagent 847-908-1605 jsinger@sagentpharma.comSource:Sagent Pharmaceuticals, Inc.